SEC Comment Letter for PEPTIDE TECHNOLOGIES, INC. (RGPX) (CIK 0001357878) (RGPX) — Jan 27, 2020

PEPTIDE TECHNOLOGIES, INC. (RGPX) (CIK 0001357878)
Date: Jan. 27, 2020 · CIK: 0001357878 · Accession: 0000000000-20-000679

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-53230

Date

January 27, 2020

Author

Not clearly detected

Form

UPLOAD

Company

PEPTIDE TECHNOLOGIES, INC. (RGPX) (CIK 0001357878)

Letter

January 27, 2020 Irene Getty Chief Financial Officer Peptide Technologies, Inc. 5348 Vegas Drive #177 Las Vegas, NV 89108 Re:Peptide Technologies, Inc. Form 10-K for Fiscal Year Ended March 31, 2019 Filed June 24, 2019 File No. 000-53230 Dear Ms. Getty: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

January 27, 2020
Irene Getty
Chief Financial Officer
Peptide Technologies, Inc.
5348 Vegas Drive #177
Las Vegas, NV 89108
Re:Peptide Technologies, Inc.
Form 10-K for Fiscal Year Ended March 31, 2019
Filed June 24, 2019
File No. 000-53230
Dear Ms. Getty:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io